Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Beam Therapeutics Inc.

Share updated data from the BEACON Phase 1/2 trial

Delivered by the deadline

AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.

Announced
5 Aug 2025
Due
31 Dec 2025
Delivered
December 2025
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“Updated Data Expected by End of 2025”

What we found

Evidence strength A What the grades mean

Beam Therapeutics presented updated data from the BEACON Phase 1/2 trial at the American Society of Hematology 2025 Annual Meeting in December 2025, meeting the year-end deadline.

  • A
    Beam Therapeutics Inc. 10-Q filed 2026-05-07 Regulatory filing · published 7 May 2026 · retrieved 2 Oct 2026 · kept permanently by the SEC
    “Updated data from the BEACON trial were presented at the American Society of Hematology 2025 Annual Meeting, in December 2025” ✓ confirmed on the page

Market reaction: the shares moved -2.6% against the S&P 500 over the three sessions around the disclosure (6 May 2026 to 11 May 2026). What this measures

Checked 2 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Clinical readout
Indicative materiality
Medium rules
Action
Share
Deliverable
BEAM-101 clinical trial data
Language
Expected (“expects”, “plans”)
In the company’s control
High
Specificity
High

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you Beam Therapeutics Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2025-BEAM-003313 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.